Progress of thrombus formation and research on the structure-activity relationship for antithrombotic drugs

X Li, T Guo, Q Feng, T Bai, L Wu, Y Liu, X Zheng… - European Journal of …, 2022 - Elsevier
Many populations suffer from thrombotic disorders such as stroke, myocardial infarction,
unstable angina and thromboembolic disease. Thrombus is one of the major threatening …

Implementation of diverse synthetic and strategic approaches to biologically active sulfamides

JJ Jun, XQ Xie - ChemistrySelect, 2021 - Wiley Online Library
Sulfamide compounds are an important class of motif in various applications in
pharmaceutical agents, agriculture, and material science. In this review, various synthetic …

[HTML][HTML] In silico drug design of benzothiadiazine derivatives interacting with phospholipid cell membranes

Z Hu, J Marti - Membranes, 2022 - mdpi.com
The use of drugs derived from benzothiadiazine, a bicyclic heterocyclic benzene derivative,
has become a widespread treatment for diseases such as hypertension, low blood sugar or …

Palladium-Catalyzed Mono-N-allylation of Unprotected Anthranilic Acids with Allylic Alcohols in Aqueous Media

H Hikawa, Y Yokoyama - The Journal of Organic Chemistry, 2011 - ACS Publications
Palladium-catalyzed N-allylation of anthranilic acids 1a–j with allyl alcohol 2a in the
presence of Pd (OAc) 2, sodium diphenylphosphinobenzene-3-sulfonate (TPPMS) in THF …

Developments in factor Xa inhibitors for the treatment of thromboembolic disorders

YK Lee, MR Player - Medicinal Research Reviews, 2011 - Wiley Online Library
Thromboembolic diseases are the leading causes of morbidity and mortality in the
developed world. Anticoagulants provide effective treatment for venous or arterial …

Recent advances in the discovery and development of direct coagulation factor Xa inhibitors

WR Gould, RJ Leadley - Current pharmaceutical design, 2003 - ingentaconnect.com
Coronary heart disease (CHD) is the leading cause of mortality and morbidity in the United
States. Currently, there are approximately 12 million Americans with CHD, which is most …

Investigation on the Anticancer Activity of Symmetric and Unsymmetric Cyclic Sulfamides

JJ Jun, D Duscharla, R Ummanni… - ACS Medicinal …, 2021 - ACS Publications
The sulfamide functional group has been extensively employed in organic synthesis to
discover probes and drugs in various applications such as cancer, human …

Design, synthesis, characterization, bioactivity and molecular docking studies of novel sulfamides

A Naderi, A Akincioglu, A Cagan… - STUDIA …, 2023 - avesis.atauni.edu.tr
Starting from commercially available 4-phenylbutanoic acids, a series of novel sulfamides
were synthesized and investigated for their inhibition properties on the human carbonic …

Contemporary medicinal-chemistry strategies for discovery of blood coagulation factor Xa inhibitors

X Hao, X Zuo, D Kang, J Zhang, Y Song… - Expert opinion on …, 2019 - Taylor & Francis
Introduction: Thrombosis is a common causal pathology for stroke, acute coronary syndrome
and venous thromboembolism disorders, which are the leading cause of death worldwide …

Progress in the discovery of factor Xa inhibitors

A Casimiro-Garcia, DA Dudley… - Expert Opinion on …, 2006 - Taylor & Francis
Factor Xa is a serine protease that has a critical role in the blood coagulation cascade by
ultimately regulating the production of thrombin. There is now ample evidence for the role of …